US Market Report for Breast Imaging 2016 - MedCore

Publisher Name :
Date: 01-Sep-2016
No. of pages: 128
Inquire Before Buying

Description

Market growth will be driven by the development of new imaging technologies as well as the aging population, which typically requires an above-average number of imaging procedures. In 2015, the largest segment in the breast imaging market was DBT. Most analog devices have already been converted to DR mammography units; thus, the significant growth in DR mammography that was seen is previous years has begun to slow. Furthermore, with the disappearance of analog and takeover of DR mammography the incentive to switch to CR mammography has become greatly reduced. With two out of four segments in decline and another undergoing the process of becoming a replacement market, the only segment remaining to drive market growth is the DBT market.

Abstract

In this report, the breast imaging market is segmented into mammography, breast ultrasound, breast MRI coils and Molecular Breast Imaging (MBI). Within the mammography market, segmentation consisting of analog mammography, computed radiography (CR) mammography, digital radiography (DR) mammography and digital breast tomosynthesis (DBT) further breaks down the market. Furthermore, the breast ultrasound market comprises manual breast ultrasound and automated breast ultrasound and the MBI market is composed of gamma imaging and positron emission mammography (PEM).

Companies


  • GE Healthcare

  • Siemens Healthcare

  • Philips Healthcare

  • Bayer

  • Hologic

  • Toshiba Medical Systems


Others include: Accutome, Agfa Healthcare, Amrad Medical, Analogic, Arcoma-IMIX, Assured Imaging Mobile Mammography, BK Medical, Bracco, C.R. Bard, Canon, Carestream Health, CMR-Naviscan, Cuattro, Del Medical, Digirad, Dilon Technologies, Ellex/Innovative Imaging, Esaote, eZono, Fischer-Giotto, FONAR, Fujifilm, Gamma Medica Inc., Guerbet, Hitachi Medical Systems, iCRco, Imaging Dynamics Company, IMRIS, Konica Minolta, Lakeshore Technologies Inc., Lantheus Medical Imaging, Machnet B.V., Mallinckrodt, MILabs, Mindray, Neusoft Medical Systems, Paradigm, Planmed OY, Quantel Medical, Rayence, Samsung Medison, Shimadzu, SonoCiné, Sonogage, Sonomed Escalon, SonoSite, Spectrum Dynamics Medical, SuperSonic Imagine, SuperSonic Imagine, Swissray, Teleflex, Terason, Tomey, TXR, ViewRay, Zonare, etc.

US Market Report for Breast Imaging 2016 - MedCore

Table of Contents

Table Of Contents I
List Of Figures Xxi
List Of Charts Xxvii

Executive Summary 1
U.S. Medical Imaging Device Market Overview 1
Competitive Analysis 3
Market Trends 6
Market Developments 8
Procedure Codes Investigated 9
Procedures Included 12
Markets Included 16
Key Report Updates 19
Version History 19

Research Methodology 20
1.1 Research Scope 20
1.2 Idata's 9-Step Methodology 20
Step 1: Project Initiation & Team Selection 20
Step 2: Prepare Data Systems and Perform Secondary Research 22
Step 3: Preparation for Interviews & Questionnaire Design 23
Step 4: Performing Primary Research 24
Step 5: Research Analysis: Establishing Baseline Estimates 26
Step 6: Market Forecast and Analysis 27
Step 7: Identify Strategic Opportunities 29
Step 8: Final Review and Market Release 30
Step 9: Customer Feedback and Market Monitoring 31

Product Assessment 32
2.1 Product Portfolios 32
2.1.1 Breast Imaging 32
2.1.1.1 Mammography 32
2.1.1.1.1 Analog Mammography Devices 33
2.1.1.1.2 Computed Radiography Mammography Devices 33
2.1.1.1.3 Digital Radiography Mammography Devices 33
2.1.1.1.4 Digital Breast Tomosynthesis Devices 33
2.1.1.2 Molecular Breast Imaging 35
2.1.1.2.1 Positron Emission Mammography Devices 35
2.1.1.2.2 Gamma Imaging Devices 35
2.1.1.3 Breast Ultrasound 36
2.1.1.3.1 Automated Breast Ultrasound Devices 36
2.1.1.3.2 Manual Breast Ultrasound Devices 37
2.1.1.4 Breast Magnetic Resonance Imaging 37
2.2 Regulatory Issues And Recalls 39
2.2.1 Breast Imaging Devices 39
2.3 Clinical Trials 42
2.3.1 Bayer 43
2.3.2 Bracco 43
2.3.3 Carestream Health 46
2.3.4 Fujifilm 49
2.3.5 GE Healthcare 52
2.3.6 Guerbet 69
2.3.7 Hologic 73
2.3.8 Lantheus Medical Imaging 74
2.3.9 Philips Healthcare 74
2.3.10 Siemens Healthcare 81
2.3.11 Toshiba Medical Systems 83

Breast Imaging Market 85
3.1 Market Overview 85
3.2 Market Analysis And Forecast 90
3.2.1 Total Mammography Market 90
3.2.1.1 Analog Mammography Market 93
3.2.1.2 Computed Radiography Mammography Market 95
3.2.1.3 Digital Radiography Mammography Market 97
3.2.1.4 Digital Tomosynthesis Market 99
3.2.2 Total Molecular Breast Imaging Market 101
3.2.2.1 Positron Emission Mammography Market 103
3.2.2.2 Gamma Imaging Market 105
3.2.3 Total Breast Ultrasound Market 107
3.2.3.1 Manual Breast Ultrasound Market 109
3.2.3.2 Automated Breast Ultrasound Market 111
3.2.4 MRI Coil Market 113
3.3 Drivers And Limiters 115
3.3.1 Market Drivers 115
3.3.2 Market Limiters 116
3.4 Competitive Market Share Analysis 117

Abbreviations 126

Appendix: Company Press Releases 128

List of Charts

Chart 1 1: Medical Imaging Device Market by Segment, U.S., 2012 - 2022 2
Chart 1 2: Medical Imaging Device Market Overview, U.S., 2012 & 2022 2
Chart 3 1: Breast Imaging Market by Segment, U.S., 2012 - 2022 88
Chart 3 2: Breast Imaging Market Breakdown, U.S., 2015 89
Chart 3 3: Breast Imaging Market Breakdown, U.S., 2022 89
Chart 3 4: Total Mammography Market by Segment, U.S., 2012 - 2022 92
Chart 3 5: Analog Mammography Market, U.S., 2012 - 2022 94
Chart 3 6: Computed Radiography Mammography Market, U.S., 2012 - 2022 96
Chart 3 7: Digital Radiography Mammography Market, U.S., 2012 - 2022 98
Chart 3 8: Digital Tomosynthesis Market, U.S., 2012 - 2022 100
Chart 3 9: Total Molecular Breast Imaging Market, U.S., 2012 - 2022 102
Chart 3 10: Positron Emission Mammography Market, U.S., 2012 - 2022 104
Chart 3 11: Gamma Imaging Market, U.S., 2012 - 2022 106
Chart 3 12: Total Breast Ultrasound Market by Segment, U.S., 2012 - 2022 108
Chart 3 13: Manual Breast Ultrasound Market, U.S., 2012 - 2022 110
Chart 3 14: Automated Breast Ultrasound Market, U.S., 2012 - 2022 112
Chart 3 15: MRI Coil Market, U.S., 2012 - 2022 114
Chart 3 16: Leading Competitors, Breast Imaging Market, U.S., 2015 125

List of Figures

Figure 1 1: Medical Imaging Device Competitor Market Share Ranking by Segment, U.S., 2015 (1 of 2) 3
Figure 1 2: Medical Imaging Device Competitor Market Share Ranking by Segment, U.S., 2015 (2 of 2) 3
Figure 1 3: Companies Researched in this Report, U.S., 2015 (1 of 2) 4
Figure 1 4: Companies Researched in this Report, U.S., 2015 (2 of 2) 5
Figure 1 5: Factors Impacting the Medical Imaging Device Market by Segment, U.S. (1 of 2) 6
Figure 1 6: Factors Impacting the Medical Imaging Device Market by Segment, U.S. (2 of 2) 7
Figure 1 7: Recent Events in the Medical Imaging Device Market, U.S., 2012 - 2015 8
Figure 1 8: Procedure Codes Investigated, U.S., 2015 (1 of 3) 9
Figure 1 9: Procedure Codes Investigated, U.S., 2015 (2 of 3) 10
Figure 1 10: Procedure Codes Investigated, U.S., 2015 (3 of 3) 11
Figure 1 11: Medical Imaging Procedures Covered, U.S., 2015 (1 of 4) 12
Figure 1 12: Medical Imaging Device Markets Covered, U.S., 2015 (1 of 3) 16
Figure 1 13: Medical Imaging Device Markets Covered, U.S., 2015 (2 of 3) 17
Figure 1 14: Medical Imaging Device Markets Covered, U.S., 2015 (3 of 3) 18
Figure 1 15: Key Report Updates 19
Figure 1 16: Version History 19
Figure 2 1: Mammography Devices by Company 34
Figure 2 2: Positron Emission Mammography Devices by Company 35
Figure 2 3: Gamma Imaging Devices by Company 36
Figure 2 4: Breast Ultrasound Devices by Company 37
Figure 2 5: Class 2 Device Recall Fujifilm Aspire HD, Full Field Digital, System 39
Figure 2 6: Class 2 Device Recall Mammomat Inspiration system 39
Figure 2 7: Class 2 Device Recall Siemens Mammomat Inspiration mammography systems 39
Figure 2 8: Class 2 Device Recall Hologic Selenia Full Field Digital Mammography System 39
Figure 2 9: Class 2 Device Recall Siemens MAMMOMAT Inspiration 40
Figure 2 10: Class 2 Device Recall Merge (Cedara) Mammo 40
Figure 2 11: Class 2 Device Recall Selenia Full Field Digital Mammography System with software versions 5.0.x and 5.1.x 40
Figure 2 12: Class 2 Device Recall Siemens Mammomat Inspiration 40
Figure 2 13: Class 2 Device Recall GE Healthcare Senographe Essential System 41
Figure 2 14: Class 2 Device Recall Soma v Automated Breast Ultrasound System 41
Figure 2 15: Class 2 Device Recall GE SENOGRAPHE 2000D FULL FIELD DIGITAL MAMMOGRAPHY SYSTEM 41
Figure 2 16: Class 2 Device Recall Siemens MAMMOMAT Inspiration 41
Figure 2 17: Perfusion CT as a Predictor for Response to Antiangiogenic Therapy 43
Figure 2 18: A Multicenter Study of Iomeron®-400 43
Figure 2 19: Retrospective Study of MRI in Pediatric Patients 44
Figure 2 20: A Pilot Trial Using BR55 Ultrasound Contrast Agent 44
Figure 2 21: Crossover Comparison of MultiHance and Dotarem (BENEFIT) 44
Figure 2 22: Multidetector Computed Tomography (MDCT) Tailored Protocol 45
Figure 2 23: Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body 45
Figure 2 24: Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body 46
Figure 2 25: CARESTREAM Vue PACS v12.1.5 CT Perfusion Clinical Protocol (CTP) 46
Figure 2 26: Clinical Evaluation of CARESTREAM Dual Energy and Digital Tomosynthesis 47
Figure 2 27: Clinical Evaluation of the Carestream PRO 3543 and PRO 3543C Digital Detectors 47
Figure 2 28: Clinical Evaluation of DRX Plus 3543 and DRX Plus 3543C Digital Detectors 48
Figure 2 29: Carestream Digital Radiography Long Length Imaging Software Data Collection Protocol (LLI-MSE) 48
Figure 2 30: A Multi-Reader Multi-Case Pivotal Trial 49
Figure 2 31: Pilot Mammography Reader Study 49
Figure 2 32: Acquisition of Breast Mammography Images 50
Figure 2 33: Study Comparing Flexible Spectral-Imaging Color Enhancement (FICE) With Olympus Narrow Band Imaging (NBI) 50
Figure 2 34: Pilot 3D Mammography Reader Study to Assess Breast Cancer Detection 50
Figure 2 35: Pilot Study Comparing Diagnostic Imaging Versus Tomosynthesis in Detection of Hip, Wrist or Tibia Injury (TOMO) 51
Figure 2 36: Collection of FUJIFILM's 3Dimensional Mammograms (3DM) 51
Figure 2 37: International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients 52
Figure 2 38: Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2 (mTBI-phase2) 52
Figure 2 39: Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis 53
Figure 2 40: Non-invasive Quantification of Liver Iron With MRI 53
Figure 2 41: Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis 54
Figure 2 42: Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis 54
Figure 2 43: Development of a MR Scanner Capable of Being Sited in a Neonatal Intensive Care Unit (Firefly) 55
Figure 2 44: Phase 4 Study to Demonstrate Prognostic Usefulness of AdreView™ Scintigraphy 55
Figure 2 45: Clinical Evaluation of an Integrated PET/MRI System (PET/MR_ZURICH) 56
Figure 2 46: Automated Breast Ultrasound and Digital Breast Tomosynthesis Screening 56
Figure 2 47: Development of an Integrated PET/MR System, Accessories and Components 57
Figure 2 48: Comparison of 18F FDG PET/CT TO PET MRI (PET/MR US) 57
Figure 2 49: Compare Rates of Agreement Between Clinical Diagnosis and Visual Assessment of DaTscan™ Images 58
Figure 2 50: Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView 58
Figure 2 51: Clinical Evaluation for GE CT System 59
Figure 2 52: A Case Collection Study for Digital Breast Tomosynthesis (DBT) 59
Figure 2 53: Assess Safety, Bio-distribution, Radiation Dosimetry and Optimize the Imaging Protocol of GEH120714 (18F) Injection 60
Figure 2 54: Magnetic Resonance Imaging Using Innovative Pulse Sequences 60
Figure 2 55: MRI Scanning of People With MR Safe Orthopedic Implants That Are Made of Metal (MRI) 60
Figure 2 56: Contrast Ultrasound Detection of Sentinel Lymph Nodes 61
Figure 2 57: Feasibility of Short Breast MRI (SBMRI) for Screening Patients at High Risk for Breast Cancer 61
Figure 2 58: PET/CT for Staging Rectal Cancer Patients With and Without EMVI-MR 62
Figure 2 59: Contrast Enhanced Spectral Mammography (CESM) Study (CONTEND) 62
Figure 2 60: Assessment of Automated Breast Ultrasound 63
Figure 2 61: Feasibility of Ultrasound Microbubble Contrast-Enhanced (CEUS) Sentinel Lymph Node Imaging 63
Figure 2 62: How Beta-amyloid Imagining Influences Clinician Diagnosis and Management 64
Figure 2 63: Dual-Energy CT in Patients With Head and Neck Squamous Cell Carcinomas 64
Figure 2 64: Use of MIBG Scan Images in PVC Ablations (PVC-MIBG) 64
Figure 2 65: Comparison of Contrast-enhanced Spectral Mammography (CESM) to MRI 65
Figure 2 66: Fluoro-L-Thymidine Positron Emission Tomography (FLT PET) vs. Adv. Magnetic Resonance (MR) Techniques 65
Figure 2 67: A Pilot, Exploratory, Non-Randomized Study of PET/CT With the Investigational Agent [18F] Fluciclatide 66
Figure 2 68: 123I-mIBG SPECT Imaging 66
Figure 2 69: Preoperative Staging and Dose Escalated Radiotherapy of Prostate Carcinoma With PET and MRI (Flucipro) 67
Figure 2 70: FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients 67
Figure 2 71: The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease 68
Figure 2 72: Imaging Biomarkers of Delayed Sequelae in Trauma Brain Injury 68
Figure 2 73: Safety and Efficacy of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization (In-Live) 69
Figure 2 74: P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI) 69
Figure 2 75: Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI 70
Figure 2 76: Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI 70
Figure 2 77: Evaluation of Gadoterate in Patients With Decreased Kidney Function 71
Figure 2 78: Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer 71
Figure 2 79: Hepatic Xenetix-CT Perfusion 72
Figure 2 80: Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis 72
Figure 2 81: Pancreatic Duct Evaluation in Autoimmune Pancreatitis: MR Pancreatography 73
Figure 2 82: Computed Tomography Versus Standard 2D Mammography Versus 3D Tomosynthesis 73
Figure 2 83: Open Label Study to Access Flurpiridaz F18 in PET MPI Verses SPECT MPI 74
Figure 2 84: Virtual Path Planning for Image-guided Needle Interventions 74
Figure 2 85: Applications of Dual-Energy Computed Tomography 75
Figure 2 86: X-ray Dose Reduction Study for Cardiac Angiography and Intervention 75
Figure 2 87: X-ray Dose Reduction Study for Endovascular Interventional Radiology 75
Figure 2 88: X-ray Dose Reduction in Electrophysiology 76
Figure 2 89: Multicenter Study of Magnetic Resonance-guided High Intensity Focused Ultrasound 76
Figure 2 90: MRI/TRUS Fusion Guided Prostate Biopsy- An Improved Way to Detect and Quantify Prostate Cancer 76
Figure 2 91: Sonalleve Fibroid Ablation Pivotal Clinical Trial for MR-HIFU of Uterine Fibroids (SOFIA) 77
Figure 2 92: Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter 77
Figure 2 93: Percutaneous Closure of Atrial Septal Defects in Children 78
Figure 2 94: Assessment of 3D Transperineal Ultrasound Imaging w/ Matrix Array Transducers in Prostate Radiotherapy 78
Figure 2 95: Radio Frequency Ablation for Atrial Flutter With Magnetic Resonance Guidance and Tracking 79
Figure 2 96: Chest Ultrasound of ER Patients With Cough or SOB 79
Figure 2 97: The Value of MultiSpectral 3 Tesla MRI in Active Surveillance of Prostate Cancer 80
Figure 2 98: Multi Modal Cardiac Imaging Prior Transcatheter Aortic Valve Implantation 80
Figure 2 99: MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases 81
Figure 2 100: Evaluation of Diagnostic Accuracy of Contrast Enhanced Dual Energy Mammography Imaging 81
Figure 2 101: Evaluation of an Innovative Medical Device Supporting Orthopedic Surgical Interventions (VIPS) 82
Figure 2 102: PET/MRI in Patients With Suspected Prostate Cancer 82
Figure 2 103: Perfusion CT as a Predictor for Response to Antiangiogenic Therapy 83
Figure 2 104: Verification of the Quantitative Accuracy of the PET/CT System Imaging Chain 83
Figure 2 105: General Investigative MRI Protocol 84
Figure 3 1: Breast Imaging Market by Segment, U.S., 2012 - 2022 (US$M) 87
Figure 3 2: Total Mammography Market by Segment, U.S., 2012 - 2022 (US$M) 91
Figure 3 3: Analog Mammography Market, U.S., 2012 - 2022 93
Figure 3 4: Computed Radiography Mammography Market, U.S., 2012 - 2022 95
Figure 3 5: Digital Radiography Mammography Market, U.S., 2012 - 2022 97
Figure 3 6: Digital Tomosynthesis Market, U.S., 2012 - 2022 100
Figure 3 7: Total Molecular Breast Imaging Market, U.S., 2012 - 2022 101
Figure 3 8: Positron Emission Mammography Market, U.S., 2012 - 2022 104
Figure 3 9: Gamma Imaging Market, U.S., 2012 - 2022 105
Figure 3 10: Total Breast Ultrasound Market by Segment, U.S., 2012 - 2022 (US$M) 108
Figure 3 11: Manual Breast Ultrasound Market, U.S., 2012 - 2022 109
Figure 3 12: Automated Breast Ultrasound Market, U.S., 2012 - 2022 111
Figure 3 13: MRI Coil Market, U.S., 2012 - 2022 114
Figure 3 14: Drivers and Limiters, Breast Imaging Market, U.S., 2015 116
Figure 3 15: Leading Competitors, Breast Imaging Market, U.S., 2015 (1 of 2) 123
Figure 3 16: Leading Competitors, Breast Imaging Market, U.S., 2015 (2 of 2) 124
Figure 5 1: Press Release Summary 129

  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • United States Ball Mill Market Report 2017
    Published: 04-Apr-2017        Price: US 3800 Onwards        Pages: 107
    In this report, the United States Ball Mill market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Ball M......
  • United States Breast Imaging Market Report 2017
    Published: 04-Apr-2017        Price: US 3800 Onwards        Pages: 103
    In this report, the United States Breast Imaging market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of B......
  • Global Digital Mammography Equipment Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 02-Apr-2017        Price: US 3480 Onwards        Pages: 123
    Mammography is specialized medical imaging that uses a low-dose x-ray system to see inside the breasts. A mammography exam, called a mammogram, aids in the early detection and diagnosis of breast diseases in women.Scope of the Report:This report focuses on the Digital Mammography Equipment in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type an......
  • Global Breast Cancer Screening (Mammography, MRI and Ultrasound) Market and Population Forecast to 2022
    Published: 06-Feb-2017        Price: US 1990 Onwards        Pages: 532
    Breast cancer is one of the major cause of mortality among women in both the developed and developing world. Early detection remains the primary defense available to patients in preventing the development of life-threatening breast cancer. Breast cancer screening is the regular examination of a woman's breasts to find breast cancer early. Screening for breast cancer primarily involves mammography. It is the best screening test for reducing the risk of dying from breast cancer. In addition to ......
  • North America Mammography Equipment Market Outlook to 2022
    Published: 01-Feb-2017        Price: US 5995 Onwards        Pages: 122
    GlobalData's new report, "North America Mammography Equipment Market Outlook to 2022", provides key market data on the North America Mammography Equipment market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segements - Film Screen Mammography Equipment and Full Field Digital Mammography Equipment. The report also provides company shares and distribution shares data for each of these market segements, and global corpora......
  • EU5 Mammography Equipment Market Outlook to 2022
    Published: 01-Feb-2017        Price: US 5995 Onwards        Pages: 181
    GlobalData's new report, "EU5 Mammography Equipment Market Outlook to 2022", provides key market data on the EU5 Mammography Equipment market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segements - Film Screen Mammography Equipment and Full Field Digital Mammography Equipment. The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of......
  • United States Magnetic Resonance Imaging (MRI) Systems Market Outlook to 2022
    Published: 01-Feb-2017        Price: US 4995 Onwards        Pages: 151
    United States Magnetic Resonance Imaging (MRI) Systems Market Outlook to 2022 Summary GlobalData's new report, "United States Magnetic Resonance Imaging (MRI) Systems Market Outlook to 2022", provides key market data on the United States Magnetic Resonance Imaging (MRI) Systems market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segements - 3T MRI Systems, 1.5T MRI Systems and 0.2T-1.2T MRI Systems.......
  • Asia-Pacific Mammography Equipment Market Outlook to 2022
    Published: 01-Feb-2017        Price: US 5995 Onwards        Pages: 133
    GlobalData's new report, "Asia-Pacific Mammography Equipment Market Outlook to 2022", provides key market data on the Asia-Pacific Mammography Equipment market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segements - Film Screen Mammography Equipment and Full Field Digital Mammography Equipment. The report also provides company shares and distribution shares data for each of these market segements, and global corporate......
  • United Kingdom Contrast Media Injectors Market Outlook to 2022
    Published: 01-Feb-2017        Price: US 4995 Onwards        Pages: 28
    United Kingdom Contrast Media Injectors Market Outlook to 2022 Summary GlobalData's new report, "United Kingdom Contrast Media Injectors Market Outlook to 2022", provides key market data on the United Kingdom Contrast Media Injectors market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segements - Angiographic Injectors, Computed Tomography (CT) Injectors and Magnetic Resonance Imaging (MRI) Injectors......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs